Recognition of Zellweger syndrome in infancy

Jennifer Grayer1

  • 1Neonatal Intensive Care Unit, Women's Hospital of Greensboro, 801 Green Valley Road, Greensboro, NC 27408, USA.

Insights

Zellweger syndrome, a peroxisome assembly disorder, impairs metabolism and damages developing neural cells. Early recognition through physical assessment and biochemical confirmation are crucial for managing this severe genetic disorder.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Developmental Neuroscience

Background:

  • Peroxisomes are vital single-membrane organelles with over 29 essential assembly proteins.
  • Peroxisome dysfunction leads to severe metabolic disruptions and is implicated in numerous genetic disorders.
  • Zellweger syndrome is a lethal autosomal recessive disorder caused by impaired peroxisome biogenesis.

Purpose of the Study:

  • To provide an overview of peroxisome function and its impact on central nervous system development.
  • To detail the clinical presentation, features, and nursing care for infants diagnosed with Zellweger syndrome.
  • To emphasize diagnostic methods, including physical assessment and biochemical confirmation, and the importance of genetic counseling and palliative care.

Main Methods:

  • Systematic physical assessment for early recognition of clinical features.
  • Magnetic resonance imaging (MRI) to detect neurological manifestations like polymicrogyria.
  • Biochemical assays for definitive diagnosis of Zellweger syndrome.

Main Results:

  • Defects in peroxisome assembly proteins lead to impaired metabolism and accumulation of toxic byproducts.
  • Zellweger syndrome is associated with abnormal neuronal migration, detectable via MRI.
  • Early identification facilitates timely intervention and supportive care.

Conclusions:

  • Peroxisome biogenesis is critical for normal cellular function and development, particularly in the central nervous system.
  • Prompt diagnosis of Zellweger syndrome through clinical and biochemical evaluation is essential for patient management.
  • Comprehensive care, including genetic counseling and palliative support, is vital for affected infants and their families.